198 related articles for article (PubMed ID: 18336530)
1. Dysregulation of matrix metalloproteinases and their tissue inhibitors is related to abnormality of left ventricular geometry and function in streptozotocin-induced diabetic minipigs.
Lu L; Zhang Q; Pu LJ; Peng WH; Yan XX; Wang LJ; Chen QJ; Zhu ZB; Michel JB; Shen WF
Int J Exp Pathol; 2008 Apr; 89(2):125-37. PubMed ID: 18336530
[TBL] [Abstract][Full Text] [Related]
2. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.
Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V
J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223
[TBL] [Abstract][Full Text] [Related]
3. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
[TBL] [Abstract][Full Text] [Related]
4. Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in rats.
Guenzinger R; Lahm H; Wottke M; Lange R
ASAIO J; 2012; 58(3):204-11. PubMed ID: 22395114
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in myocardial collagen, matrix metalloproteinases, and their tissue inhibitors in the left ventricular myocardium in experimental chronic mitral regurgitation in rodents.
Corporan D; Onohara D; Hernandez-Merlo R; Sielicka A; Padala M
Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1269-H1278. PubMed ID: 30141979
[TBL] [Abstract][Full Text] [Related]
6. Cardiac remodeling in erythropoietin-transgenic mice.
Briest W; Homagk L; Baba HA; Deten A; Rassler B; Tannapfel A; Wagner KF; Wenger RH; Zimmer HG
Cell Physiol Biochem; 2004; 14(4-6):277-84. PubMed ID: 15319531
[TBL] [Abstract][Full Text] [Related]
7. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells.
Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M
Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928
[TBL] [Abstract][Full Text] [Related]
8. The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.
Gaertner R; Jacob MP; Prunier F; Angles-Cano E; Mercadier JJ; Michel JB
J Mol Cell Cardiol; 2005 Jan; 38(1):193-204. PubMed ID: 15623436
[TBL] [Abstract][Full Text] [Related]
9. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.
Tanaka K; Essick EE; Doros G; Tanriverdi K; Connors LH; Seldin DC; Sam F
J Am Heart Assoc; 2013 Mar; 2(2):e005868. PubMed ID: 23537813
[TBL] [Abstract][Full Text] [Related]
10. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury.
Prakobwong S; Pinlaor S; Yongvanit P; Sithithaworn P; Pairojkul C; Hiraku Y
Int J Parasitol; 2009 Jun; 39(7):825-35. PubMed ID: 19168069
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices.
Li YY; Feng Y; McTiernan CF; Pei W; Moravec CS; Wang P; Rosenblum W; Kormos RL; Feldman AM
Circulation; 2001 Sep; 104(10):1147-52. PubMed ID: 11535571
[TBL] [Abstract][Full Text] [Related]
12. [Extracellular matrix accumulation and expression of gelatinases and their tissue inhibitors in a mechanically unloaded heart model].
Wang L; Zhou X; Yun JL; Zeng S; Li YM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 Aug; 25(3):303-7. PubMed ID: 21155219
[TBL] [Abstract][Full Text] [Related]
13. Elevation of tumor necrosis factor-alpha, interleukin-1beta and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes.
Lu L; Zhang Q; Pu LJ; Xu XW; Zhang RY; Zhang JS; Hu J; Yang ZK; Lü AK; Ding FH; Shen J; Chen QJ; Lou S; Fang DH; Shen WF
Chin Med J (Engl); 2007 Mar; 120(6):479-84. PubMed ID: 17439741
[TBL] [Abstract][Full Text] [Related]
14. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR
Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051
[TBL] [Abstract][Full Text] [Related]
15. The effects of exercise training on cardiac matrix metalloproteinases activity and cardiac function in mice with diabetic cardiomyopathy.
Dede E; Liapis D; Davos C; Katsimpoulas M; Varela A; Mpotis I; Kostomitsopoulos N; Kadoglou NPE
Biochem Biophys Res Commun; 2022 Jan; 586():8-13. PubMed ID: 34818584
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
17. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
18. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition.
Li H; Simon H; Bocan TM; Peterson JT
Cardiovasc Res; 2000 May; 46(2):298-306. PubMed ID: 10773234
[TBL] [Abstract][Full Text] [Related]
19. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
Shukla V; Kumar Shakya A; Dhole TN; Misra UK
Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
[TBL] [Abstract][Full Text] [Related]
20. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
